Samir Devani News Today

Troubled artificial heart maker Carmat is appealing to key shareholders led by Airbus to invest new funds to avoid the collapse of the 30-year-old venture.

Troubled artificial heart maker Carmat is appealing to key shareholders led by Airbus to invest new funds to avoid the collapse of the 30-year-old venture dating back to a chance meeting between...

By Michal Aleksandrowicz, Tim Hepher and Laura Lenkiewicz PARIS (Reuters) - Troubled artificial heart maker Carmat is appealing to key shareholders le...

Valneva SE (NASDAQ:VALN) Q2 2023 Earnings Call Transcript September 21, 2023 Valneva SE misses on earnings expectations. Reported EPS is $0.26 EPS, expectations were $0.36. Operator: Good day, and thank you for standing by. Welcome to the Valneva Half Year 2023 Financial Results Call and Webcast. [Operator Instructions] Please note that today’s conference is being […]

Operator: Good morning, and welcome to the BioXcel Therapeutics Fourth Quarter and Full Year 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Operator: Good day, and thank you for standing by. Welcome to the Valneva Reports Nine-Month 2022 Results and Provides Corporate Updates Call. At this time, all participants are in a listen-only mode.

French drugmaker Valneva said on Monday it is in talks with a potential partner on producing an updated version of its Covid-19 vaccine that targets new va..

PARIS, Sept 26 (Reuters) - French drugmaker Valneva VLS.PA said on Monday it is in talks with a potential partner on producing an updated version of its Covid-19 vaccine that targets new variants of the disease, sending its shares up.

PARIS — French drugmaker Valneva said on Monday it is in talks with a potential partner on producing an updated version of its COVID-19 vaccine that targets…

With climate change spurring more cases of tick-borne Lyme disease, drugmaker Valneva is betting big on a vaccine as it looks beyond disappointing sales of its COVID shot.